CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

Science. 1990 Sep 21;249(4975):1431-3. doi: 10.1126/science.1698311.


Leukocytes respond to lipopolysaccharide (LPS) at nanogram per milliliter concentrations with secretion of cytokines such as tumor necrosis factor-alpha (TNF-alpha). Excess secretion of TNF-alpha causes endotoxic shock, an often fatal complication of infection. LPS in the bloodstream rapidly binds to the serum protein, lipopolysaccharide binding protein (LBP), and cellular responses to physiological levels of LPS are dependent on LBP. CD14, a differentiation antigen of monocytes, was found to bind complexes of LPS and LBP, and blockade of CD14 with monoclonal antibodies prevented synthesis of TNF-alpha by whole blood incubated with LPS. Thus, LPS may induce responses by interacting with a soluble binding protein in serum that then binds the cell surface protein CD14.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute-Phase Proteins*
  • Animals
  • Antibodies, Monoclonal / immunology
  • Antigens, CD / immunology*
  • Antigens, Differentiation, Myelomonocytic / immunology*
  • CD18 Antigens
  • Carrier Proteins / immunology*
  • Erythrocytes / immunology
  • Leukocytes / immunology
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides / immunology*
  • Macrophages / immunology
  • Membrane Glycoproteins*
  • Receptors, Leukocyte-Adhesion / immunology
  • Sheep
  • Tumor Necrosis Factor-alpha / biosynthesis


  • Acute-Phase Proteins
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD18 Antigens
  • Carrier Proteins
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides
  • Membrane Glycoproteins
  • Receptors, Leukocyte-Adhesion
  • Tumor Necrosis Factor-alpha
  • lipopolysaccharide-binding protein